| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000019628 |
| Receipt No. | R000022678 |
| Scientific Title | Comparison of fasle negative rates of urea breath test in patients after PCAB-based eradication therapy for clarithromycin resistance H.pylori |
| Date of disclosure of the study information | 2015/11/05 |
| Last modified on | 2020/02/06 (Ver. 4) |
| Basic information | ||
| Public title | Comparison of fasle negative rates of urea breath test in patients after PCAB-based eradication therapy for clarithromycin resistance H.pylori | |
| Acronym | Efficacy of UBT after PCAB-based H.pylori eradication | |
| Scientific Title | Comparison of fasle negative rates of urea breath test in patients after PCAB-based eradication therapy for clarithromycin resistance H.pylori | |
| Scientific Title:Acronym | Efficacy of UBT after PCAB-based H.pylori eradication | |
| Region |
|
|
| Condition | ||
| Condition | Helicobacter pylori infection | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the efficacy of urea breath test in patients after PCAB-based eradication therapy for clarithromycin resistance H.pylori. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | False-negative rate of urea breath test |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | urea breath test, stool H.pylori antigen test | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with clarythromycin resistance H.pylori infection who take eradication treatment. Patients who test efficacy of H.pylori eradication therapy by urea breath test. Patients who give a written informed consent. | |||
| Key exclusion criteria | Pregnancy or lactation. Past history of allergy for the drugs used in H.pylori eradication. Severe liver dysfunction, Severe renal dysfunction, Severe heart dysfunction. Patients who are disqualified for the study by physicians. | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University Hospital | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 236-0004 | ||||||
| Address | Fukuura3-9, Kanazawa, Yokohama, Kanagawa, Japan | ||||||
| TEL | 045-261-5656 | ||||||
| ssue@yokohama-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University Hospital | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 236-0004 | ||||||
| Address | Fukuura3-9, Kanazawa, Yokohama, Kanazawa, Japan | ||||||
| TEL | 045-261-5656 | ||||||
| Homepage URL | |||||||
| ssue@yokohama-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Yokohama City University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yokohama City University(Basic research expenditures) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Yokohama City University Ethics Committee |
| Address | Fukuura3-9, Kanazawa-ku, Yokohama city, Kanagawa |
| Tel | 045-3707627 |
| rinri@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 横浜市立大学附属病院(神奈川県)Yokohama City University Hospital(kanagawa) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022678 |